Drug profile · INN
vadadustat
VAFSEO
vadadustat (VAFSEO) is a egl nine homolog 3 inhibitor. Associated with Akebia Europe Limited. Route of administration: oral. Current US regulatory status: approved.
Drug details — vadadustat
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 18
- Programs
- 13
- Data quality
- 0.89
Quick answer
vadadustat (VAFSEO) is a egl nine homolog 3 inhibitor. Associated with Akebia Europe Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Egl nine homolog 3 inhibitor
Primary target: Egl nine homolog 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11857543
Compositions and methods for treating anemia
granted -
US 11844756
Compositions and methods for treating anemia
granted -
US 11324734
Compositions and methods for treating anemia
granted -
US 11267785
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
granted -
US 11065237
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 10738010
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
granted -
US 10246416
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
granted -
US 10149842
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 9987262
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 9776969
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
granted -
US 9701636
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 9145366
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
granted -
US 8940773
Prolyl hydroxylase inhibitors and methods of use
granted -
US 8865748
Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
granted -
US 8598210
Prolyl hydroxylase inhibitors and methods of use
granted -
US 8343952
Prolyl hydroxylase inhibitors and methods of use
granted -
US 8323671
Prolyl hydroxylase inhibitors and methods of use
granted -
US 8133894
N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
granted
Frequently asked questions
What is vadadustat?
vadadustat (VAFSEO) is a egl nine homolog 3 inhibitor. Associated with Akebia Europe Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vadadustat?
VAFSEO is a marketed brand name for vadadustat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vadadustat?
vadadustat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.